Eli Lilly says 'deeply concerned' by bribery allegations in China

SHANGHAI (Reuters) – U.S. drugmaker Eli Lilly and Co said it was “deeply concerned” about allegations published in a Chinese newspaper that it spent more than 30 million yuan ($4.90 million) to bribe doctors in China to prescribe the firm’s medicines instead of rival products.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.